Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Takeda Pharma Ges.m.b.H., a prominent subsidiary of Takeda Pharmaceutical Company Limited, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1781, Takeda has evolved into a global leader in the pharmaceutical industry, focusing on areas such as oncology, gastroenterology, and rare diseases.
The company is renowned for its innovative therapies, including biologics and advanced medicines, which are designed to address unmet medical needs. Takeda's commitment to research and development has positioned it as a key player in the market, with notable achievements in expanding access to life-saving treatments. With a rich history and a strong emphasis on patient-centric solutions, Takeda Pharma Ges.m.b.H. continues to make significant contributions to global health.
+58 vs industry average
Takeda Pharma Ges.m.b.H.’s score of 100 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Takeda Pharma Ges.m.b.H. yet.
Takeda Pharma Ges.m.b.H., headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Takeda Pharmaceutical Company Limited, which cascades its climate commitments and emissions data.
As part of its parent company's initiatives, Takeda Pharma is aligned with various climate strategies, including those set by the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Takeda Pharma Ges.m.b.H. have not been disclosed.
The overarching climate commitments from Takeda Pharmaceutical Company Limited indicate a focus on reducing emissions across all scopes, although detailed figures for Scope 1, 2, and 3 emissions specific to Takeda Pharma Ges.m.b.H. are not provided. The company is committed to sustainability and aims to contribute to global efforts in mitigating climate change, but further details on their specific targets or performance metrics remain unspecified.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Takeda Pharma Ges.m.b.H. yet.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more